PATENT CLAIM ANALYSIS

Application Number: 15747571
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "04400A"]

Abstract:
The present invention relates to RNAi agents, e.g., double stranded RNAi agents, targeting a xanthine dehydrogenase (XDH) gene, and methods of using such double stranded RNAi agents to inhibit expression of an XDH gene and methods of treating subjects having an XDH-associated disease.

Claim (Index 98):
A method of preventing at least one symptom in a subject having a disease or disorder that would benefit from reduction in XDH expression, the method comprising administering to the subject a prophylactically effective amount of the dsRNA agent of any one of  claims 1 - 4 ,  8 ,  27 ,  73 - 77 , and  79  or a pharmaceutical composition of any one of  claims 86 - 92 , thereby preventing at least one symptom in the subject having a disorder that would benefit from reduction in XDH expression.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 86.0
- Lexical Diversity: 1.51515
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14976261', '15670132', '14947025', '15399820', '14650128']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7837717566904691
- 35 USC 102 Novelty (BERT): 0.5514948303239574
- Combined Prediction Score: 0.7605440640538179
- Mean Citation Score: 382.727662
- Max Citation Score: 405.0581
- Similarity Product: 340.6778930327535

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test